|
Cohort 1
|
Cohort 2
|
|---|
| |
HC
|
MCI
|
AD
|
HC
|
FTD
|
|---|
|
Cohort size
|
14
|
26
|
56
|
24
|
27
|
|
Men/women
|
7/7
|
10/16
|
15/41
|
11/13
|
17/10
|
|
Age (years)
|
68.29 ± 8.99
|
72.0 ± 8.49
|
77.77 ± 6.69
|
67.03 ± 5.05
|
68.87 ± 7.48
|
|
GDS
|
2.07 ± 0.26
|
3.15 ± 0.37
|
4.64 ± 1.02
|
1 ± 0
|
3.76 ± 0.99
|
|
MMSE
|
29.21 ± 1.05
|
26.92 ± 2.22
|
16.05 ± 7.23
|
28.5 ± 1.69
|
25.5 ± 3.76
|
- All data are shown as mean ± SD
- HC cognitively healthy controls, MCI mild cognitive impairment, AD Alzheimer’s disease, FTD frontotemporal dementia, MMSE Mini-Mental State Examination, GDS Global Deterioration Scale
